(Q33657589)
Statements
1 reference
Regulatory decision strategy for entry of a novel biological therapeutic with a clinically unmonitorable toxicity into clinical trials: pre-IND meetings and a case example (English)
1 reference
L E Black
1 reference
A M Bendele
1 reference
R A Bendele
1 reference
P M Zack
1 reference
M Hamilton
1 reference
1 January 1999
1 reference
1 reference
27
1 reference
22-26
1 reference
Identifiers
1 reference
1 reference